American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology Screening Guidelines for the Prevention and Early Detection of Cervical Cancer
about
Clinical significance of human papillomavirus genotypingNew strategies for human papillomavirus-based cervical screeningHuman Papillomavirus Infection, Infertility, and Assisted Reproductive OutcomesSecondary solid cancer screening following hematopoietic cell transplantationRecommendations on screening for cervical cancerCervical cancer screening practice and knowledge among Hispanic migrant and seasonal farmworkers of MichiganKnowledge of Patients' Human Papillomavirus Status at the Time of Cytologic Review Significantly Affects the Performance of Cervical Cytology in the ATHENA Study.Provider-Identified Barriers to Cervical Cancer Screening and Perceptions Toward Self-Collection of Human Papillomavirus in Southwest Virginia.Point-Counterpoint: Cervical Cancer Screening Should Be Done by Primary Human Papillomavirus Testing with Genotyping and Reflex Cytology for Women over the Age of 25 Years.A population-based evaluation of cervical screening in the United States: 2008-2011.Optimal positive cutoff points for careHPV testing of clinician- and self-collected specimens in primary cervical cancer screening: an analysis from rural ChinaUtility of molecular tests in cytopathologyCervical Cancer Screening With Human Papillomavirus DNA and Cytology in Japan.Is 58% sensitivity for detection of cervical intraepithelial neoplasia 3 and invasive cervical cancer optimal for cervical screening?A Discussion of High-Risk HPV in a 6-Year-Old Female Survivor of Child Sexual Abuse.Comparing the Cervista HPV HR test and Hybrid Capture 2 assay in a Dutch screening population: improved specificity of the Cervista HPV HR test by changing the cut-off.Hybrid Capture 2 is as effective as PCR testing for high-risk human papillomavirus in head and neck cancers.Update on prevention and screening of cervical cancer.Comparative evaluation of three commercial systems for detection of high-risk human papillomavirus in cervical and vaginal ThinPrep PreservCyt samples and correlation with biopsy resultsA brief chronicle of cytology: from Janssen to Papanicolaou and beyond.PEG1/MEST and IGF2 DNA methylation in CIN and in cervical cancer.Women's intentions to self-collect samples for human papillomavirus testing in an organized cervical cancer screening programAutomated recommendation for cervical cancer screening and surveillance.Cervical dysplasia and high-risk human papillomavirus infections among HIV-infected and HIV-uninfected adolescent females in South Africa.Resequencing microarray technology for genotyping human papillomavirus in cervical smears.HPV mRNA is more specific than HPV DNA in triage of women with minor cervical lesions.Prevalence of human papillomavirus in 5,072 consecutive cervical SurePath samples evaluated with the Roche cobas HPV real-time PCR assay.HPV16 methyl-haplotypes determined by a novel next-generation sequencing method are associated with cervical precancerPerformance of self-collected cervical samples in screening for future precancer using human papillomavirus DNA testing.Patient concerns about human papillomavirus testing and 5-year intervals in routine cervical cancer screening.Natural history of progression of HPV infection to cervical lesion or clearance: analysis of the control arm of the large, randomised PATRICIA study.A prospective study of age trends of high-risk human papillomavirus infection in rural China.Primary screening for cervical cancer based on high-risk human papillomavirus (HPV) detection and HPV 16 and HPV 18 genotyping, in comparison to cytology.Patient knowledge and beliefs as barriers to extending cervical cancer screening intervals in Federally Qualified Health CentersCervical cancer screening adherence among HIV-positive female smokers from a comprehensive HIV clinicHigh risk human papillomavirus persistence among HIV-infected young women in South Africa.Comparison of HPV genotyping and methylated ZNF582 as triage for women with equivocal liquid-based cytology results.HPV prevalence and risk of pre-cancer and cancer in regular immigrants in Italy: results from HPV DNA test-based screening pilot programs.Are patients with inflammatory bowel disease on chronic immunosuppressive therapy at increased risk of cervical high-grade dysplasia/cancer? A meta-analysis.Implementation of the National Breast and Cervical Cancer Early Detection Program: the beginning.
P2860
Q26771981-4D70E095-A15B-49B5-9CE3-26EF65A27388Q26851699-1FF962E5-3563-43D2-B1F7-B4F29355AA51Q28088327-A047BA29-340C-405B-B406-D060DA3E160CQ28088369-E5359C7F-0C82-496F-8AB2-FCF1114FBC91Q28282866-23FDCE3F-D87E-45F1-8459-44EF2092F7F4Q28384913-A6990128-5BBF-455E-B6DF-36346396436EQ30276085-2474D1EA-E5D1-4ACA-ADE1-E1C8164015FEQ30276307-EA4ABCA0-6F73-4A08-AD84-2415EDE93B7FQ30299986-8624AEE0-BDF8-4BBB-BDBB-87C94AD3BADFQ30405438-9582B779-1875-4675-AC48-6382FA28DA71Q30409312-8DC02543-9B6C-47AA-80D8-4D95925843A3Q33555932-0C8623A3-4429-427C-AA2A-9D7FEB4AD89FQ33669871-B42D9C62-AF14-42BC-A990-450C2CF2C3ACQ33760459-EC58A9E9-5AB8-46FF-870D-BFFCB1939ED2Q33767915-CD5C9A43-28F1-4029-B4E4-0C455557DA00Q33933176-952BD6D2-87DE-4E22-9390-BA44827266C4Q33976804-78068DC1-E749-4B56-9D65-8AA5F8412A19Q34031269-39CD5B0C-E291-4B3C-BB24-164E8930F28FQ34298145-A91D43A1-4F96-42E2-90FF-D3EACF76A872Q34341242-CC3DFC7D-404D-4041-A1D4-2D6CB322AFF7Q34351507-975D3B56-23BE-49D1-9AE3-AF6B344BE535Q34374999-47F965F5-5550-4CBC-A2AC-D044A26B4163Q34428256-9AD0ADD7-87BA-4FEA-A6CA-8BE0FF4B45C6Q34441738-725F0335-A09D-4F12-A4DB-2B8A1201A321Q34482539-1E43464A-CBA8-4492-ABA7-661EFDC36B83Q34535660-C80024E4-0EDB-421D-9E7E-5478C45A0712Q34637954-AE71613E-7F93-4C4E-AF7D-51B6A842404BQ34675069-039012D9-7825-45A0-80AB-1E0A379BE1E5Q34736619-E72AE4F7-99B3-402F-B2D3-E1F61ED55885Q35007699-E19D9A40-CCB8-42DF-8B5C-51304B6F9C73Q35048280-7109FC1A-9C3C-4EE2-8591-DE11C4CA668DQ35100159-A9839FF0-3466-46F4-B728-6D1976C4BFFBQ35203306-98613C53-0EFB-4E2B-AE9C-A03421CC0595Q35219371-7A3BF2A5-5F8F-4A2D-AD12-2C340AB08D16Q35247235-DF4AE46D-CC39-4058-9A05-C623663DE1EDQ35418185-E59AB350-EF3E-4F1B-8C06-3D97A8DF89CFQ35568812-4FFDD5C0-3B69-4EB6-844E-A9434EAB0150Q35595268-B2D514B7-3395-4DEE-A6A0-B139ADEC1138Q35690978-495F2FA8-39B5-4889-9ED6-81E4A7A32948Q35785086-5FE4C48D-2E12-4090-8151-1EE3C22045EF
P2860
American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology Screening Guidelines for the Prevention and Early Detection of Cervical Cancer
description
article
@en
im April 2012 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована у квітні 2012
@uk
name
American Cancer Society, Ameri ...... y Detection of Cervical Cancer
@en
American Cancer Society, Ameri ...... y Detection of Cervical Cancer
@nl
type
label
American Cancer Society, Ameri ...... y Detection of Cervical Cancer
@en
American Cancer Society, Ameri ...... y Detection of Cervical Cancer
@nl
prefLabel
American Cancer Society, Ameri ...... y Detection of Cervical Cancer
@en
American Cancer Society, Ameri ...... y Detection of Cervical Cancer
@nl
P2093
P2860
P356
P1476
American Cancer Society, Ameri ...... y Detection of Cervical Cancer
@en
P2093
Alan G. Waxman
Ann T. Moriarty
Anna-Barbara Moscicki
David C. Wilbur
Debbie Saslow
Diane Solomon
Eduardo L. Franco
Evan R. Myers
Francisco A. R. Garcia
Herschel W. Lawson
P2860
P304
P356
10.1309/AJCPTGD94EVRSJCG
P407
P577
2012-04-01T00:00:00Z